概括
纤维素蛋白的12,000达尔顿域与血小板受体结合,特别是糖蛋白IIIa. 这种相互作用是由六胺介导的,突出了关键的纤维内素-血小板粘附机制.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 血液学 血液学 血液学
背景情况:
- 纤维蛋白是一种关键的细胞外基质蛋白,参与细胞粘附.
- 血小板在血液静止和血栓形成中起着至关重要的作用.
- 了解纤维素-血小板相互作用对于血液静止和血栓形成研究至关重要.
研究的目的:
- 为了确定与血小板相互作用的纤维素蛋白的特定域.
- 为了确定参与纤维素结合的血小板表面受体.
- 为了阐明纤维蛋白-血小板粘附的分子机制.
主要方法:
- 利用化学交叉链接和单克隆抗体来识别蛋白质相互作用.
- 采用了与纤维菌素碎片的亲和性染色学.
- 竞争的结合试验使用已知的抑制性六.
主要成果:
- 纤维素蛋白的12,000达尔顿域特别与血小板受体结合.
- 这种纤维内克丁域直接与血小板糖蛋白IIIa相互作用.
- 一种阻断纤维细胞粘附的六也抑制了纤维内素与血小板的结合.
- 血小板糖蛋白IIIa和IIb复合体与纤维素菌素细胞附着片段结合.
结论:
- 12000达尔顿的纤维连结蛋白域被确定为血小板相互作用的主要媒介.
- 甘氨酸蛋白IIIa是这个纤维素蛋白域的关键血小板受体.
- 这些发现确定了纤维素-血小板粘附中的特定分子参与者.
相关概念视频
Fibril-associated Collagen
2.7K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
2.7K
Fibronectins Connect Cells with ECM
2.9K
Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
2.9K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K
Drug Binding to Blood Components
680
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
680


